aTyr Pharma Announces Second Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trial Programs

Go back to aTyr Pharma Announces Second Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trial Programs
Life Technologies Corporation (NASDAQ: LIFE) Delayed: 18.90 -0.55 (2.83%)
Previous Close $19.45    52 Week High $10.93 
Open $19.00    52 Week Low $2.48 
Day High $19.60    P/E 6.97 
Day Low $18.50    EPS $2.71 
Volume 951,299